NTLA

Intellia Therapeutics

Biotech · 7 tracked clinical trials

Clinical Pipeline

TrialPhaseStatusIndication
NCT06128629 PHASE3 RECRUITING Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
NCT06672237 PHASE3 RECRUITING Neuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease
NCT06634420 PHASE3 ACTIVE_NOT_RECRUITING Hereditary Angioedema
NCT06379789 PHASE1, PHASE2 RECRUITING Hemophilia B
NCT05120830 PHASE1, PHASE2 ACTIVE_NOT_RECRUITING Hereditary Angioedema
NCT06262399 — ENROLLING_BY_INVITATION Hereditary Angioedema
NCT05697861 — ENROLLING_BY_INVITATION Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Wild-Type Transthyretin Cardiac Amyloidosis

Partnerships & Collaborations

PartnerTypeAnnouncedDetails
No partnerships tracked yet.

Recent news

DateHeadlineSource
2026-09-01 NTLA Stock Surges 35% Overnight: Retail Mood Peaks Ahead Of First-Ever Phase 3 Readout For Gene-Editing Therapy - Stocktwits Google News
2026-09-01 NTLA Jumps Premarket On Positive Late-Stage Trial Data For Gene-Editing Therapy — Retail Says Buy Now Before It’s Too Late - Stocktwits Google News
2026-08-28 Science Blog called an early trial a "magic wand" in 2024. Two years on, a placebo-controlled Phase 3 trial cut attack rates 87 percent — and Intellia has filed for FDA approval of what would be the f Google News
2026-08-27 Intellia Therapeutics (NTLA) Stock May Be Fully Priced Despite Its 92% Slide - simplywall.st Google News
2026-08-25 Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEONARD JOHN M - Moomoo Google News
2026-08-25 Cathie Wood’s ARK buys Intellia stock, sells Roblox - Investing.com Google News
2026-08-25 NTLA Looks 7.1% Undervalued on GF Value™ - GuruFocus Google News
2026-08-24 Intellia Therapeutics (NTLA) CEO sells shares around $13 - Stock Titan Google News
2026-08-21 NTLA Stock Rockets After Hours Before Critical Data For Genetic Disorder Therapy - Stocktwits Google News
2026-08-21 Intellia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo Google News
2026-08-21 Intellia Therapeutics Inc (XTER:38I) Valuation: Fairly Valued - GuruFocus Google News
2026-08-21 Intellia Therapeutics Inc (XTER:38I) Stock News, Headlines & Updates - GuruFocus Google News
2026-08-21 Intellia Therapeutics Inc (XTER:38I) Competitors 2026 - GuruFocus Google News
2026-08-21 Intellia Therapeutics Inc Stock Operating Data - GuruFocus Google News
2026-08-21 NTLA Stock Price Prediction 2025-2026 | Intellia Therapeutics Inc Forecast - 24/7 Wall St. Google News
2026-08-20 Intellia Therapeutics (NASDAQ:NTLA) Shares Down 6.4% - Time to Sell? - MarketBeat Google News
2026-08-20 John M. Leonard to sell 22,675 Intellia (NASDAQ: NTLA) shares - Stock Titan Google News
2026-08-20 Bank of America Corp DE Grows Stock Position in Intellia Therapeutics, Inc. $NTLA - MarketBeat Google News
2026-08-19 Intellia Therapeutics (NASDAQ:NTLA) Stock Price Up 10.7% - Here's What Happened - MarketBeat Google News
2026-08-18 Will Narrowing Six‑Month Losses Shape Intellia Therapeutics' (NTLA) Gene‑Editing Investment Narrative? - simplywall.st Google News